Compare RTO & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RTO | MEDP |
|---|---|---|
| Founded | 1925 | 1992 |
| Country | United Kingdom | United States |
| Employees | 64084 | N/A |
| Industry | Business Services | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.4B | 14.9B |
| IPO Year | N/A | 2016 |
| Metric | RTO | MEDP |
|---|---|---|
| Price | $33.56 | $494.07 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 13 |
| Target Price | $35.00 | ★ $498.25 |
| AVG Volume (30 Days) | ★ 1.4M | 271.9K |
| Earning Date | 03-09-2026 | 04-22-2026 |
| Dividend Yield | ★ 1.56% | N/A |
| EPS Growth | N/A | ★ 20.98 |
| EPS | N/A | ★ 15.28 |
| Revenue | N/A | N/A |
| Revenue This Year | $16.98 | $13.19 |
| Revenue Next Year | $4.31 | $7.75 |
| P/E Ratio | $222.16 | ★ $32.79 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $21.68 | $250.05 |
| 52 Week High | $34.09 | $628.92 |
| Indicator | RTO | MEDP |
|---|---|---|
| Relative Strength Index (RSI) | 62.45 | 55.24 |
| Support Level | $30.09 | $489.09 |
| Resistance Level | N/A | $501.30 |
| Average True Range (ATR) | 0.63 | 16.54 |
| MACD | 0.26 | 5.43 |
| Stochastic Oscillator | 86.20 | 57.30 |
Rentokil Initial is the largest global provider of route-based pest control and commercial hygiene services, operating in over 90 countries, with its largest operations in the United States following the acquisition of Terminix. The group also offers a range of specialist route-based services, including office and commercial space plant care, property care, and workwear rentals. The group serves a diverse client base of global food producers, hotel chains, industrial goods companies, restaurants, and individual residential customers.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.